These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 19278069)
21. Response to the letter "Actigraphic evaluation for patients with attention deficit/hyperactivity disorder". Labbe A; Joober R Am J Med Genet B Neuropsychiatr Genet; 2013 Apr; 162B(3):293. PubMed ID: 23475815 [No Abstract] [Full Text] [Related]
22. St. John's wort may diminish methylphenidate's efficacy in treating patients suffering from attention deficit hyperactivity disorder. Niederhofer H Med Hypotheses; 2007; 68(5):1189. PubMed ID: 17254717 [No Abstract] [Full Text] [Related]
23. Several concerns arise when the results are interpreted. Yang R; Mao S; Li R; Zhao Z Hum Psychopharmacol; 2011 Jan; 26(1):86-7; author reply 88. PubMed ID: 23055417 [No Abstract] [Full Text] [Related]
24. [Hallucinations caused by the introduction of methylphenidate at low doses]. Aguilera-Albesa S; Yoldi-Petri ME; Molins-Castiella T; Durá-Travé T Rev Neurol; 2010 Aug; 51(4):254-5. PubMed ID: 20648469 [No Abstract] [Full Text] [Related]
25. Spontaneous coronary artery dissection in a patient on methylphenidate for attention deficit hyperactivity disorder. Mahmood MM; Wright RA Int J Cardiol; 2016 Nov; 222():830-831. PubMed ID: 27522384 [No Abstract] [Full Text] [Related]
26. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD? Niederhofer H Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351 [No Abstract] [Full Text] [Related]
30. Opening the white boxes: the licensing documentation of efficacy and safety of psychotropic medicines for children. Aagaard L; Thirstrup S; Hansen EH Pharmacoepidemiol Drug Saf; 2009 May; 18(5):401-11. PubMed ID: 19326364 [TBL] [Abstract][Full Text] [Related]
33. More frequent diagnosis of attention deficit-hyperactivity disorder. Swanson JM; Lerner M; Williams L N Engl J Med; 1995 Oct; 333(14):944. PubMed ID: 7666894 [No Abstract] [Full Text] [Related]
34. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. Kaufmann R; Goldberg-Stern H; Shuper A J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115 [TBL] [Abstract][Full Text] [Related]
36. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
38. Adherence to methylphenidate therapy in a pediatric population: a preliminary investigation. Brown RT; Borden KA; Clingerman SR Psychopharmacol Bull; 1985; 21(1):28-36. PubMed ID: 3983335 [No Abstract] [Full Text] [Related]
39. Medicating children with attention deficit disorder. Wiener JM Pediatrics; 1988 Nov; 82(5):812. PubMed ID: 3186370 [No Abstract] [Full Text] [Related]
40. US parents sue psychiatrists for promoting Ritalin. Charatan F BMJ; 2000 Sep; 321(7263):723. PubMed ID: 10999893 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]